Tocilizumab for the treatment of systemic juvenile idiopathic arthritis

Arthritis (juvenile idiopathic, systemic) - tocilizumab: review decision April 2015 information

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appendix A - GE decision paper - March 2015 (PDF 107 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: review proposal information

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appendix A - matrix of stakeholders (PDF 100 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appendix B - GE proposal paper January 2015 (PDF 239 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: equality impact assessment (PDF 77 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: final appraisal determination information

Arthritis (juvenile idiopathic, systemic) - tocilizumab: final appraisal determination (PDF 254 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: response to consultee, commentator and public comments on the appraisal consultation document (ACD) (PDF 262 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: consultee and commentator comments on the ACD

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD (PDF 745 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - PAS template (PDF 238 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - PSA (PDF 195 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - additional analysis as requested by ERG (PDF 160 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - erratum PSA for PAS (PDF 230 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: NRAS comments on ACD (PDF 357 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: BSPAR comments on ACD (PDF 122 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Abbott comments on ACD (PDF 70 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: ARUK comments on ACD (PDF 292 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: comments on the ACD from Dr Jeremy Camilleri (nominated by the Welsh Government) (PDF 6.7 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: additional ERG critique post ACD by Kleijnen Systematic Reviews (PDF 449 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation document information

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - evaluation report

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - pre-meeting briefing (PDF 332 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - Evidence Review Group report (PDF 1019 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - ERG report Errata (PDF 148 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - Evidence Review Group report (factual accuracy check) (PDF 248 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - manufacturer submission

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - manufacturer submission from Roche (PDF 2.66 MB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - clarification letter (PDF 131 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - clarification response (PDF 570 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - patient group, professional group and NHS organisation submission statements

Arthritis Care (PDF 60 KB)

British Health Professionals in Rheumatology (PDF 72 KB)

British Society for Paediatric and Adolescent Rheumatology (PDF 90 KB)

National Rheumatoid Arthritis Society (PDF 951 KB)

Royal College of Pathologists (PDF 69 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - expert written personal statements

Camilleri (PDF 179 KB)

Copeland (PDF 62 KB)

Gebbie (PDF 156 KB)

Wood (PDF 20 KB)

Arthritis (juvenile idiopathic) - tocilizumab; final scope (PDF 32 KB)

Arthritis (juvenile idiopathic) - tocilizumab; final matrix (PDF 34 KB)

Arthritis (juvenile idiopathic) - tocilizumab: scoping equality impact assessment (PDF 15 KB)

Arthritis (juvenile idiopathic) - tocilizumab; draft scope (PDF 33 KB)

Arthritis (juvenile idiopathic) - tocilizumab; provisional matrix (PDF 34 KB)